# US 2025/0059259 A1 · KNOCKOUT OF ptsP GENE ELEVATES ACTIVE GENE EXPRESSION

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0059259 A1
- Document ID: US20250059259A1
- Status: Published application
- Kind: A1
- Application number: 18/724,015
- Filed: 2022-12-22
- Published: 2025-02-20
- Earliest claimed: 2022-12-22
- Assignees: AbSci LLC
- Applicants: Absci Corporation
- Inventors: Matthew Weinstock
- Web page: https://patentgrep.com/patent/US20250059259A1

## CPC

- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C12N 9/0065: {acting on hydrogen peroxide as acceptor (1.11)}
- C07K 14/245: Escherichia (G)
- C12N 9/1223: {Phosphotransferases with a nitrogenous group as acceptor (2.7.3)}
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C12Y 111/01: Peroxidases (1.11.1)
- C12Y 207/03009: Phosphoenolpyruvate-protein phosphotransferase (2.7.3.9)
- C07K 2319/02: containing a signal sequence
- C12N 2800/101: for bacteria
- C12N 2830/002: inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C12R 2001/01: Bacteria or Actinomycetales {; using bacteria or Actinomycetales}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

Variant or mutant prokaryotic cells are disclosed that express elevated or increased levels of a wide variety of active proteins. Also disclosed are methods of producing the elevated or increased levels of active encoded proteins.

## Claims

### Claim 1

A prokaryotic organism comprising a defective PtsP pathway and a heterologous expressible coding region or gene.

### Claim 2 (depends on 1)

The prokaryotic organism according to claim 1 comprising a defective PTS operon.

### Claim 3 (depends on 2)

The prokaryotic organism according to claim 2 comprising a defective ptsl, ptsO, ptsN, ptsP, or manX gene.

### Claim 4

(canceled)

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The prokaryotic organism according to claim 1 wherein the heterologous expressible coding region or gene is located on an episome.

### Claim 7 (depends on 1)

The prokaryotic organism according to claim 1 wherein the heterologous expressible coding region or gene is located in the chromosome of the prokaryotic organism.

### Claim 8

(canceled)

### Claim 9

(canceled)

### Claim 10 (depends on 1)

The prokaryotic organism according to claim 1 wherein the organism comprises a ptsP− coding region or gene.

### Claim 11 (depends on 10)

The prokaryotic organism according to claim 10 wherein the ptsP− coding region or gene comprises at least a partial deletion of the sequence set forth in SEQ ID NO:1.

### Claim 12 (depends on 11)

The prokaryotic organism according to claim 11 wherein the ptsP− coding region or gene comprises a deletion of no more than 10 contiguous nucleotides of SEQ ID NO:1.

### Claim 13 (depends on 10)

The prokaryotic organism according to claim 10 wherein the ptsP− coding region or gene comprises at least one missense or nonsense mutation compared to the sequence set forth in SEQ ID NO:1.

### Claim 14 (depends on 1)

The prokaryotic organism according to claim 1 wherein the prokaryotic organism comprises an intracellular environment that is more oxidizing than a wild-type prokaryotic organism of the same species.

### Claim 15 (depends on 14)

The prokaryotic organism according to claim 14 comprising the ahpCΔ allele of the gene encoding peroxiredoxin and an inactivating mutation of
(a) trxB encoding thioredoxin,
(b) gor encoding glutaredoxin reductase, or
(c) both trxB and gor.

### Claim at position 16

-19. (canceled)

### Claim 20 (depends on 1)

The prokaryotic organism according to claim 1 comprising ahpCΔ, trxB−, gor−, ΔscpA-argK-scpBC, and at least one inactivating mutation in the araBAD operon.

### Claim 21

(canceled)

### Claim 22 (depends on 1)

The prokaryotic organism according to claim 1 further comprising ΔaraEp::J23104.

### Claim 23

(canceled)

### Claim 24 (depends on 1)

The prokaryotic organism according to claim 1 further comprising an inducible promoter in operable linkage to the expressible coding region or gene.

### Claim 25 (depends on 24)

The prokaryotic organism according to claim 24 wherein the inducible promoter and the expressible coding region or gene are located on an episome.

### Claim 26 (depends on 24)

The prokaryotic organism according to claim 24 wherein the inducible promoter is ParaBAD.

### Claim 27

(canceled)

### Claim 28 (depends on 1)

The prokaryotic organism according to claim 1 further comprising ParaC in operable linkage to araC, PprpR in operable linkage to prpR, and ParaBAD in operable linkage to the expressible coding region or gene.

### Claim 29

(canceled)

### Claim 30 (depends on 1)

The prokaryotic organism according to claim 1 further comprising at least one chaperone coding region or gene.

### Claim 31

(canceled)

### Claim 32 (depends on 1)

The prokaryotic organism according to claim 1 wherein the expressible coding region or gene encodes an antibody chain, an antibody fragment thereof, or a chimeric antigen receptor.

### Claim 33

A method comprising:
(a) introducing an episome comprising an expressible coding region or gene into a prokaryotic host cell comprising a defective PtsP pathway; and
(b) culturing the prokaryotic host cell under conditions compatible with expression of the coding region or gene;
wherein the level of expression of active encoded product from the heterologous expressible coding region or gene is greater than the level of expression of active encoded product from the coding region or gene in a wild-type counterpart of the prokaryotic host cell.

### Claim at position 31

-54. (canceled)
